Follow the 天臣医疗 stock price and the full directors' dealings record of the company, a publicly traded company based in China. Shares trade on the CN market, under the authority of SSE / SZSE (CSRC). Operating in the Health Care sector, 天臣医疗 has recorded 11 insider filings. Market capitalisation: €1.8bn. The latest transaction was reported on 27 January 2026 (Sale). Among the most active insiders: 丁水澄. Every trade is accessible without an account.
11
Insider Decl.
n/a
Thresholds
€39,577
1 ops.
Buy Volume
€5m
10 ops.
Sell Volume
7Σ signal
Buys €39,577€5m Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 8,193 of 28,796 companies
62.2
score / 100
Value
43
Quality
82
FCF yld-1.1%
Earn yld4.8%
EV/EBITDA16.9x
ROE14%
Gross mgn64%
Net mgn26%
Debt/EBITDA0.5x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
天臣医疗 is a company operating in the healthcare and pharmaceutical sector, listed on the Shanghai Stock Exchange. It focuses on the development and commercialization of innovative medical products.